Aspen seals deal with Serum Institute to make vaccines for Africa
Aspen to bottle four vaccines used in routine childhood immunisation programmes across the continent
SA’s biggest pharmaceutical manufacturer, Aspen Pharmacare, has concluded a 10-year agreement with the Serum Institute of India (SII) to bottle four vaccines it will market and distribute under its own brand in Africa.
The agreement is expected to improve Africa’s security of supply and use spare capacity in Aspen’s Gqeberha facility, which has lines standing idle due to lower-than-expected sales of Johnson & Johnson’s Covid-19 vaccines. Aspen reached an agreement last year to bottle J&J’s shot, and then extended the deal to produce the jab under its own brand, Aspenovax, but it has seen dwindling demand from J&J and received no orders for its own-brand shot...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.